A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Status:
Completed
Trial end date:
2009-04-13
Target enrollment:
Participant gender:
Summary
This a Phase III trial designed to determine if IV casopitant plus dexamethasone and
ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and
ondansetrone alone following the administration of moderately emetogenic oxaliplatin-based
chemotherapy.